Celestica's stock recently experienced a sharp correction without any fundamental issues to justify the sell-off. The company's CCS segment is driving strong revenue and margin growth, supported by increased spending from hyperscalers and new platform launches. Recent equity dilution was used to expand capacity, but liquidity remains strong with no expected large share issuances soon. Analysts see nearly 100% upside potential over the next year based on a 20x earnings multiple for 2027 and continued growth execution.
Following the recent sharp correction in Celestica's stock, the shares have rebounded with a 4.96% gain on the day. On Pluang, CLS trades at USD 235.00 as of Nov 11, 2026 13:21 WIB, well below its 52-week high of USD 472.40. The stock shows strong buying interest with 100% of orders on Pluang being buys and a typical hold time of 36 days, indicating active investor engagement.
